Stock listing
Telomir Pharmaceuticals, Inc.
Selected listing: TELO · NASDAQ · USD · US
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), Health Technology. Latest release Oct 6, 2026: Telomir Pharmaceuticals Secures $5.6 Million Financing…
- Ticker
- NASDAQ:TELO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. (TELO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
October 5, 2026
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
September 17, 2026
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
September 14, 2026
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
August 10, 2026
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model
June 14, 2026
Research Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. company profile
View the public company page for Telomir Pharmaceuticals, Inc. on 6ix.
Telomir Pharmaceuticals, Inc. news
Read company news and market updates connected to Telomir Pharmaceuticals, Inc..
Telomir Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Telomir Pharmaceuticals, Inc..